bioMérieux Deutschland GmbH, Nürtingen (HRB 220743)

vitro diagnostics tests vitro diagnostics vitro diagnostic tests vitro diagnostic testing viruses virus venous thrombosis urinary tract infections serum septicemia sample safety of products rubella rapid tests quality of bioMérieux tests quality of bioMérieux diagnostics pulmonary embolism public health product safety product quality product contaminations plasma pioneering spirit phlebitis personalized service patient health patient care pathogenic microorganisms pathogenic bacteria parasites parasite nosocomial infections molecular diagnostics molecular biology tests molecular biology miniaturization microorganisms microorganism identification microorganism microbiology microbiological tests microbiological quality markers management with Myla long-term partnership laboratory performance services lab efficiency infectious mononucleosis infectious agents industrial microbiology industrial microbiological control industrial biology industrial applications immunotherapy immunocompromised patients immunoassays immune system?s response hormones hepatitis heathcare-associated infections heart attack healthcare spending healthcare professionals health of consumers fungus food safety food quality extraction of nucleic acids diagnostics tests diagnostics diagnostic solutions decentralized testing consumer safety consumer health clinical microbiology chromID cardiovascular emergencies cardiovascular diseases cancers cancer blood biomérieux Customer Service biology bioMérieux?s Quality Policy bioMérieux's strategy bioMérieux's public health initiatives bioMérieux's presence worldwide bioMérieux's management committee bioMérieux's labor relations bioMérieux's history bioMérieux's head office bioMérieux's facts figures bioMérieux's environmental commitment bioMérieux's bioMérieux strategy bioMérieux solutions bioMérieux software bioMérieux set of standards bioMérieux set of processes bioMérieux services bioMérieux reagents bioMérieux quality policy bioMérieux local subsidiary teams bioMérieux instruments bioMérieux figures bioMérieux clinical diagnostics website bioMérieux clinical diagnostics applications bioMérieux clinical applications bioMérieux Internal Audit bioMérieux Industry website bioMérieux Global Customer Service bioMérieux 50th bioMérieux bacterium bacterial infection bacteria automation solutions automation appropriate antibiotic treatment antigens antigen-antibody reaction antibodies antibiotic susceptibility testing airIDEAL Traceability VITEK MS VITEK 2 Compact VITEK 2 VIDAS ® 3 VIDAS UP VIDAS Transgene Terms TEMPO Scientific Salmonella RNA gene sequences QuantiSwab NucliSENS easyMAG Mérieux NutriSciences Mérieux Développement Marcy l'Etoile Lyon Marcel Mérieux MFT Listeria Institut Mérieux Infectious diseases IMAccess ID/AST HIV Glossary Global Compact Full Microbiology Laboratory Automation FilmArray Ebola Test FMLA Etest Dr. Charles Mérieux DiversiLab Culture media Count-Tact 3P CHEMUNEX BioThreat-E test BioMérieux Media Contacts BacT/ALERT 3D Dual-T BacT/ALERT Alain Mérieux API ABL Inc. 41 subsidiaries 150 countries